FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2097642308> ?p ?o ?g. }

• W2097642308 endingPage "2028" @default.
• W2097642308 startingPage "2022" @default.
• W2097642308 abstract "ABSTRACT Existing licensed anthrax vaccines are administered parenterally and require multiple doses to induce protective immunity. This requires trained personnel and is not the optimum route for stimulating a mucosal immune response. Microencapsulation of vaccine antigens offers a number of advantages over traditional vaccine formulations, including stability without refrigeration and the potential for utilizing less invasive routes of administration. Recombinant protective antigen (rPA), the dominant antigen for protection against anthrax infection, was encapsulated in poly- l -lactide 100-kDa microspheres. Alternatively, rPA was loosely attached to the surfaces of microspheres by lyophilization. All of the microspheric formulations were administered to A/J mice with a two-dose schedule by either the intramuscular route, the intranasal route, or a combination of these two routes, and immunogenicity and protective efficacy were assessed. An intramuscular priming immunization followed by either an intramuscular or intranasal boost gave optimum anti-rPA immunoglobulin G titers. Despite differences in rPA-specific antibody titers, all immunized mice survived an injected challenge consisting of 10 3 median lethal doses of Bacillus anthracis STI spores. Immunization with microencapsulated and microsphere-associated formulations of rPA also protected against aerosol challenge with 30 median lethal doses of STI spores. These results show that rPA can be encapsulated and surface bound to polymeric microspheres without impairing its immunogenicity and also that mucosal or parenteral administration of microspheric formulations of rPA efficiently protects mice against both injected and aerosol challenges with B. anthracis spores. Microspheric formulations of rPA could represent the next generation of anthrax vaccines, which could require fewer doses because they are more potent, are less reactogenic than currently available human anthrax vaccines, and could be self-administered without injection." @default.
• W2097642308 created "2016-06-24" @default.
• W2097642308 creator A5003246227 @default.
• W2097642308 creator A5007348853 @default.
• W2097642308 creator A5008066104 @default.
• W2097642308 creator A5024571471 @default.
• W2097642308 creator A5046252773 @default.
• W2097642308 creator A5051902759 @default.
• W2097642308 creator A5060501018 @default.
• W2097642308 creator A5071552976 @default.
• W2097642308 creator A5088609944 @default.
• W2097642308 creator A5089989453 @default.
• W2097642308 date "2002-04-01" @default.
• W2097642308 modified "2023-09-24" @default.
• W2097642308 title "Mucosal or Parenteral Administration of Microsphere-Associated <i>Bacillus anthracis</i> Protective Antigen Protects against Anthrax Infection in Mice" @default.
• W2097642308 cites W1491410981 @default.
• W2097642308 cites W1536607091 @default.
• W2097642308 cites W1765888134 @default.
• W2097642308 cites W1902591105 @default.
• W2097642308 cites W1966241976 @default.
• W2097642308 cites W1990457946 @default.
• W2097642308 cites W2004693684 @default.
• W2097642308 cites W2015148410 @default.
• W2097642308 cites W2029821093 @default.
• W2097642308 cites W2032266561 @default.
• W2097642308 cites W2034556692 @default.
• W2097642308 cites W2042616926 @default.
• W2097642308 cites W2061952369 @default.
• W2097642308 cites W2085520026 @default.
• W2097642308 cites W2105077075 @default.
• W2097642308 cites W2122451783 @default.
• W2097642308 cites W2147649244 @default.
• W2097642308 cites W2154610143 @default.
• W2097642308 cites W2156440716 @default.
• W2097642308 cites W2265803435 @default.
• W2097642308 doi "https://doi.org/10.1128/iai.70.4.2022-2028.2002" @default.
• W2097642308 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/127835" @default.
• W2097642308 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/11895967" @default.
• W2097642308 hasPublicationYear "2002" @default.
• W2097642308 type Work @default.
• W2097642308 sameAs 2097642308 @default.
• W2097642308 citedByCount "90" @default.
• W2097642308 countsByYear W20976423082012 @default.
• W2097642308 countsByYear W20976423082013 @default.
• W2097642308 countsByYear W20976423082014 @default.
• W2097642308 countsByYear W20976423082015 @default.
• W2097642308 countsByYear W20976423082016 @default.
• W2097642308 countsByYear W20976423082017 @default.
• W2097642308 countsByYear W20976423082018 @default.
• W2097642308 countsByYear W20976423082019 @default.
• W2097642308 countsByYear W20976423082020 @default.
• W2097642308 countsByYear W20976423082021 @default.
• W2097642308 countsByYear W20976423082022 @default.
• W2097642308 countsByYear W20976423082023 @default.
• W2097642308 crossrefType "journal-article" @default.
• W2097642308 hasAuthorship W2097642308A5003246227 @default.
• W2097642308 hasAuthorship W2097642308A5007348853 @default.
• W2097642308 hasAuthorship W2097642308A5008066104 @default.
• W2097642308 hasAuthorship W2097642308A5024571471 @default.
• W2097642308 hasAuthorship W2097642308A5046252773 @default.
• W2097642308 hasAuthorship W2097642308A5051902759 @default.
• W2097642308 hasAuthorship W2097642308A5060501018 @default.
• W2097642308 hasAuthorship W2097642308A5071552976 @default.
• W2097642308 hasAuthorship W2097642308A5088609944 @default.
• W2097642308 hasAuthorship W2097642308A5089989453 @default.
• W2097642308 hasBestOaLocation W20976423082 @default.
• W2097642308 hasConcept C104317684 @default.
• W2097642308 hasConcept C123894998 @default.
• W2097642308 hasConcept C147483822 @default.
• W2097642308 hasConcept C159654299 @default.
• W2097642308 hasConcept C167508917 @default.
• W2097642308 hasConcept C203014093 @default.
• W2097642308 hasConcept C22070199 @default.
• W2097642308 hasConcept C22889606 @default.
• W2097642308 hasConcept C2777289321 @default.
• W2097642308 hasConcept C2780239966 @default.
• W2097642308 hasConcept C2780801004 @default.
• W2097642308 hasConcept C2780868878 @default.
• W2097642308 hasConcept C32611913 @default.
• W2097642308 hasConcept C40767141 @default.
• W2097642308 hasConcept C41810244 @default.
• W2097642308 hasConcept C523546767 @default.
• W2097642308 hasConcept C54355233 @default.
• W2097642308 hasConcept C55493867 @default.
• W2097642308 hasConcept C71924100 @default.
• W2097642308 hasConcept C85663871 @default.
• W2097642308 hasConcept C86803240 @default.
• W2097642308 hasConcept C8891405 @default.
• W2097642308 hasConcept C89423630 @default.
• W2097642308 hasConceptScore W2097642308C104317684 @default.
• W2097642308 hasConceptScore W2097642308C123894998 @default.
• W2097642308 hasConceptScore W2097642308C147483822 @default.
• W2097642308 hasConceptScore W2097642308C159654299 @default.
• W2097642308 hasConceptScore W2097642308C167508917 @default.
• W2097642308 hasConceptScore W2097642308C203014093 @default.
• W2097642308 hasConceptScore W2097642308C22070199 @default.
• W2097642308 hasConceptScore W2097642308C22889606 @default.
• W2097642308 hasConceptScore W2097642308C2777289321 @default.

• next